Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
58 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Unknown  Preparing for Adolescent HIV Vaccine Trials in South Africa:
Conditions: HIV Infection;   HIV Infections
Intervention:
2 Unknown  Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
3 Recruiting Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study
Condition: Acquired Immune Deficiency Syndrome Virus
Intervention: Biological: Live attenuated Vaccine- Fluenz Tretra
4 Recruiting Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals' HPV vaccine 580299;   Biological: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine (Gardasil)
5 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
6 Recruiting Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Conditions: Influenza;   HIV;   Tuberculosis
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
7 Recruiting Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
Conditions: Solid Organ Transplant Recipient (Liver, Kidney, Heart);   Rheumatologic Disorder;   Human Immunodeficiency Virus (HIV);   Bone Marrow Transplant (BMT);   Dialysis
Interventions: Biological: Fluzone High Dose;   Biological: Fluzone
8 Unknown  Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
9 Recruiting Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Saline Solution;   Biological: D-GPEi;   Biological: M-GPE
10 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
11 Not yet recruiting Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers
Condition: HIV Infection
Interventions: Biological: LIPO-5;   Biological: MVA HIV-B (MVATG17401);   Biological: GTU®-MultiHIV B: 0.5 mL IM via Biojector® 2000 and 0.5mL IntraDermic, 3 shots
12 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
13 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: rVSV;   Biological: IL-12 pDNA adjuvant;   Biological: HIV-Mag pDNA
14 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
15 Not yet recruiting Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX B/E®;   Biological: Placebo vaccine
16 Recruiting Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
Conditions: HIV Infection;   HIV Seronegativity
Intervention:
17 Recruiting The Safety and Immunogenicity of a Potential HIV Vaccine
Condition: HIV Infections
Intervention: Biological: CN54gp140 mixed with GLA-AF
18 Not yet recruiting Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda
Condition: HIV/AIDS and Infections
Intervention: Biological: Hepatitis B vaccine
19 Unknown  Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
Condition: HIV Infection
Intervention: Biological: Hepavax-Gene
20 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years